Preventing Stockpiling, Preparing for the “New Normal” in the PBM Industry

Alan Lotvin, president of CVS Caremark, discusses how pharmacy benefit managers are handling the drug supply chain and managing patient needs during the coronavirus pandemic, including preventing stockpiling and providing digital solutions. He describes new PBM practices that will continue when the country moves into the “new normal.” He also touches on CVS Health’s approach to testing.

The Coronavirus Outbreak: Effective Early Intervention, Lessons Learned

Mark Lurie, Associate Professor of Epidemiology at Brown University, digs into his experience tracking the spread of infectious diseases to provide a perspective on the coronavirus outbreak. He covers effective intervention, contact tracing, and offers his outlook on the pandemic’s trajectory.

Answering Providers’ Questions About Telehealth, CTeL 2020 Updates

Christa Natoli, executive director of the Center for Telehealth and eHealth Law (CTeL), notes common provider questions about the telehealth regulatory landscape and gives her perspective on the state of telehealth during the coronavirus pandemic. She discusses emerging trends in acute, behavioral, and mental healthcare and previews CTeL’s virtual conference in June 2020.
Thanks to our sponsor: Vivify Health, developer of the nation’s leading remote patient monitoring platform, provides the best-connected care management and patient engagement solutions for better outcomes and ROI. Our virtual visit platform provides patients with the utmost care and empowers our clinicians to work seamlessly. We service more than 800 hospitals, home care agencies, and health plans. Vivify Pathways, the company’s mobile cloud-based platform, powers holistic remote care management through personalized care plans, biometric data monitoring, multi-channel patient education, and functionality configured to each patient’s unique needs.
www.vivifyhealth.com

Designing Patient-Centered Clinical Trials Using Diversity, Inclusion

Christian Rubio, vice president of Strategic Advancement for Global Genes, explains why supporting more diversity in clinical trials is both good science and good morals and outlines how researchers can take strides towards greater inclusion of underrepresented populations. He also delves into the current state of rare disease research and COVID-19’s impact on the field.

Engaging Health Plan Members and Supporting Providers During A Crisis

Kurt Herzer, MD, head of population health at Oscar Health, explains how payers are maintaining strong member engagement during the coronavirus. He details how population segmentation and deploying existing channels of communication can help address patient needs and uphold high quality member experience. He also describes how to partner with and support providers and community-based organizations as they assist members.

Partnering With the FCC to Expand Telehealth During the COVID-19 Crisis and Beyond

Brendan Carr, a commissioner with the Federal Communications Commission, explains how hospitals and health systems can take advantage of new funding opportunities initiated by the FCC to expand broadband connectivity and improve telehealth adoption. Carr details how the $100 million Connected Health Pilot Program and, more recently, the $200 million COVID-19 Telehealth Program are giving healthcare providers much-needed support to launch and expand innovative telehealth programs tackling both coronavirus and non-coronavirus care. He also explains how programs like this will position rural and urban providers for telehealth momentum after the emergency.

Employing A Patient-Centered Population Health Strategy During COVID-19

Vanessa Guzman, Associate Vice President at Montefiore Health System, defines population health as “everyone’s responsibility.” She describes how to build a culture that views the patient as a person, focusing on whole person health by leveraging appropriate technologies and community-based partnerships. She also addresses how the New York-based healthcare system is applying these strategies to the coronavirus pandemic.

Enabling Interoperability and Data Exchange During COVID-19

Mariann Yeager, chief executive officer of The Sequoia Project, describes the current state of interoperability in light of the recent ONC final interoperability rule. She covers what stakeholders need to be involved, the challenges that the pandemic poses to interoperability, and how circumstances could accelerate the shift toward interoperability

Maintaining Telehealth Progress Beyond COVID-19, ATA 2020 Updates

Ann Mond Johnson, chief executive officer of the American Telemedicine Association, gives an overview of the telehealth landscape, in light of the pandemic. She explores areas where telehealth use could be expanded, explains how momentum can continue once the pandemic ends, and provides details on the ATA’s 2020 conference.
Thanks to our sponsor:
Vivify Health, developer of the nation’s leading remote patient monitoring platform, provides the best-connected care management and patient engagement solutions for better outcomes and ROI. Our virtual visit platform provides patients with the utmost care and empowers our clinicians to work seamlessly. We service more than 800 hospitals, home care agencies, and health plans. Vivify Pathways, the company’s mobile cloud-based platform, powers holistic remote care management through personalized care plans, biometric data monitoring, multi-channel patient education, and functionality configured to each patient’s unique needs.
https://www.vivifyhealth.com/

Keeping Remote Work, Telehealth Secure During the COVID-19 Pandemic

Caleb Barlow, president and chief executive officer of Cynergistek, shares best practice VPN strategies, in the wake of the COVID-19 pandemic and the increase in telehealth and remote work. He outlines recommended tech and policies, as well as the current threat landscape as hackers seek to profit from the national emergency.